Clinical trial
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Withdrawn
Key facts
| NCT number | NCT00179842 |
|---|---|
| Title | Immune Ablation and Stem Cell Support for Crohn's Disease |
| Official title | Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn Disease |
| Intervention type | Procedure |
| Interventions | Stem Cell Transplant |
| Enrollment | 0 |
| Start date | Mar 22, 2007 |
| Primary completion | Dec 19, 2008 |
| Completion | Dec 19, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 10, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: